Agenesis of Uterus
Agenesis of the uterus means the uterus did not form during fetal development. It is most often part of a condition called Mayer-Rokitansky-Küster-Hauser syndrome, in which the uterus and the upper portion of the vagina are absent or underdeveloped while the ovaries, the external genitalia, and the hormonal system are entirely normal. Because the ovaries function normally, puberty proceeds as expected—breasts develop, body shape changes, and hormone levels are typical for age. The condition usually comes to light in the mid-teens when periods do not begin despite otherwise normal development. It is a significant diagnosis with real implications for sexual function and for how a woman may have children, and both of those are addressable.
What is it?
The uterus, fallopian tubes, cervix, and upper two-thirds of the vagina all develop from a pair of structures called the Müllerian ducts, which appear early in fetal life. The ovaries develop separately, from entirely different tissue, and the lower third of the vagina and the external genitalia develop from different tissue again.
This separation of origins is the key to understanding the condition. When the Müllerian ducts fail to develop, the structures derived from them are absent—the uterus and the upper vagina—while everything derived from other tissue is completely normal. The ovaries form and function normally. The external genitalia appear entirely typical. The lower vagina is present, though it ends as a short pouch rather than continuing upward.
This is why a woman with uterine agenesis goes through puberty normally. Her ovaries produce oestrogen and progesterone on the usual schedule, breasts develop, body shape changes, and pubic and underarm hair appears. She ovulates each month. The only thing that does not happen is menstruation, because there is no uterine lining to shed.
The condition is most commonly called Mayer-Rokitansky-Küster-Hauser syndrome, usually shortened to MRKH, after the physicians who described aspects of it. It is also referred to as Müllerian agenesis or Müllerian aplasia.
Two forms are distinguished.
Type 1, sometimes called isolated MRKH, involves absence of the uterus and upper vagina with no other abnormalities.
Type 2 involves additional differences, most often of the kidneys and urinary tract—an absent kidney, a kidney in an abnormal position, or a horseshoe kidney—and sometimes of the spine or other skeletal structures. Hearing differences and, less commonly, heart abnormalities are described. The association with the kidneys reflects the close developmental relationship between the reproductive and urinary systems.
A minority of women have small remnants of uterine tissue on one or both sides, sometimes called rudimentary horns or uterine buds. Most contain no functioning lining and cause no symptoms. In a smaller number, functioning endometrium is present within a structure that has no outlet, so menstrual blood accumulates each month and causes progressive cyclical pelvic pain. This is one of the few situations in which the condition causes physical symptoms beyond absent periods, and it usually requires surgical removal of the affected tissue.
The cause is not established in most cases. The condition occurs sporadically in the great majority, with no affected relatives and no identified environmental trigger. Familial clustering is described in a minority of families, suggesting a genetic contribution, and a number of candidate genes and chromosomal regions have been implicated, but no single reliable genetic test exists. Importantly, it is not caused by anything a mother did during pregnancy, and this reassurance is worth stating explicitly, since it is a common and unnecessary source of guilt.
The presentation is characteristic and largely confined to one feature.
Primary amenorrhoea—periods never starting—in a girl with otherwise normal pubertal development is the classic presentation. Because breast development, growth, and body changes have all proceeded normally, the absence of periods can be attributed to late development for some time before investigation begins. Most diagnoses are made between the ages of 15 and 18.
Some young women present instead through difficulty with tampon use or with attempted intercourse, discovering that the vagina is short and ends blindly. Others are identified when imaging performed for another reason—often a kidney investigation in childhood—shows the uterus is absent.
Cyclical pelvic pain, worsening month on month in a girl who is not menstruating, suggests functioning uterine tissue with no outlet and warrants prompt assessment.
The diagnostic pathway needs to distinguish this condition from others that present similarly, and this matters considerably because the implications differ.
Pelvic ultrasound is the first investigation. It typically shows no uterus between the bladder and rectum, with ovaries present. A practical caution applies: in this condition the ovaries often sit higher in the pelvis than usual and can be difficult to see on ultrasound, and their apparent absence has sometimes led to incorrect conclusions. Failure to identify ovaries on ultrasound should prompt further imaging rather than a diagnosis of ovarian failure.
MRI is the definitive imaging investigation. It confirms the absence of the uterus, characterises any rudimentary tissue and whether it contains functioning lining, measures vaginal length, and assesses the kidneys and spine in the same study.
Karyotype testing is essential. It confirms a typical female chromosome pattern and distinguishes MRKH from complete androgen insensitivity syndrome, in which a person with XY chromosomes develops female external characteristics but also has no uterus. The two can look similar on initial assessment, but the underlying situation, the hormonal profile, the presence of internal testes requiring management, and the counselling needs all differ substantially. Hormone testing showing normal female ovarian function supports the diagnosis and separates it from causes of ovarian failure.
Kidney imaging and spinal assessment are recommended in all cases, given the frequency of associated differences.
The differential also includes an imperforate hymen or transverse vaginal septum, in which the uterus is present but the outflow is blocked—these cause cyclical pain with a visible or palpable collection of blood and are entirely different in management—and constitutional delay of puberty, which is excluded by the normal pubertal development already present.
Important to Know
This diagnosis is usually made in adolescence and is significant, and the way it is communicated matters a great deal. Care should be coordinated by a specialist centre with experience in Müllerian anomalies, typically involving adolescent gynaecology, specialist nursing, psychology, and reproductive medicine.
Several facts are worth establishing clearly at the outset, because they are frequently misunderstood.
A woman with this condition is female in every biological and social sense. Her chromosomes are female, her ovaries and hormones are female, her external anatomy is female, and her identity is unaffected by the diagnosis. Sexual development, attraction, and function are not determined by the presence of a uterus.
Sexual intercourse is possible for the large majority, either without any intervention where the existing vagina is sufficiently long, or after treatment to create adequate length. Sexual sensation and the capacity for orgasm are unaffected, since these depend on the clitoris and external structures, which are normal.
Ovarian function is normal, so hormone replacement is not required and menopause occurs at the usual age.
Biological children are possible. The ovaries produce normal eggs, which can be retrieved and fertilised, and carried by a surrogate. This is the most established route to genetic parenthood, though its legal status and accessibility vary considerably between countries.
Creating vaginal length is the first practical treatment question, and only where a woman wishes to pursue it. There is no medical urgency, and the timing should follow her readiness rather than an external schedule.
Vaginal dilation is the recommended first-line approach and is successful for the large majority—commonly reported at around 85 to 95 percent in specialist centres. Graduated dilators are used regularly over a period of months, applying gentle pressure that gradually lengthens the existing vaginal tissue. It requires commitment and is considerably easier with structured support from a specialist nurse or physiotherapist, which substantially improves success rates. Because it avoids surgery and its complications, it is the preferred option in all major guidelines.
Surgical creation of a vagina is reserved for women in whom dilation fails or is unsuitable. Several techniques exist, using bowel segments, skin grafts, peritoneum, or laparoscopic traction methods. All require dilation or regular intercourse afterwards to maintain length, so surgery does not remove the need for ongoing management. Each technique has its own complication profile, and this decision benefits from specialist input.
Uterine transplantation has moved from experimental to clinically available in a small number of centres worldwide, with a growing number of live births reported. It involves transplantation from a living or deceased donor, immunosuppressive medication during the period the uterus is in place, pregnancy achieved through in vitro fertilisation, delivery by caesarean section, and removal of the transplanted uterus afterwards so immunosuppression can stop. It is a major undertaking with significant risks, availability remains limited, and it is not suitable for everyone—but it is a genuine option and represents a substantial change from the position even a decade ago.
Removal of rudimentary uterine tissue is indicated where it contains functioning lining causing cyclical pain, and is usually performed laparoscopically.
Psychological support is not an optional extra in this condition. The diagnosis typically arrives in mid-adolescence, a period when identity and belonging are central concerns, and it touches on femininity, sexuality, and the expectation of motherhood simultaneously. Distress, grief, and difficulty telling partners, friends, and family are usual rather than exceptional responses. Access to psychological support and to peer contact with other women who have the condition consistently improves outcomes, and organised patient support groups exist and are valued by many. The way the diagnosis is first explained has a lasting effect, and specialist centres are attentive to this in a way that general services may not be.
Family members deserve mention. Since a minority of cases show familial clustering, sisters with delayed or absent periods should be assessed. Most women have no affected relatives, and genetic testing is not routinely informative.
Ongoing care is generally minimal once vaginal length is established and any rudimentary tissue managed. Cervical screening is not required, since there is no cervix. Contraception is not needed for pregnancy prevention, though barrier protection against sexually transmitted infection remains relevant. General health care proceeds as for any woman, with attention to kidney function where a kidney abnormality is present.
Care is coordinated by specialist centres, and referral is worthwhile even where a diagnosis has already been made elsewhere, since experience with this condition is concentrated and outcomes—particularly for dilation therapy and for psychological adjustment—are better where it is managed regularly. Imaging, karyotype, and clinical findings are interpreted together, and the diagnosis should be confirmed with MRI and karyotype rather than ultrasound alone.
Patient education plays an important role. Understanding that ovarian function and hormones are normal, that sexual function can be normal, that biological children are possible through surrogacy and potentially through transplantation, that dilation avoids surgery for most women, and that psychological support is a core part of care rather than an admission of weakness all contribute to appropriate care.
Red flag symptoms include severe or progressively worsening cyclical pelvic pain in a girl who is not menstruating, which suggests obstructed functioning uterine tissue and warrants prompt assessment; a palpable lower abdominal mass with cyclical pain; absent periods by the age of 15 with normal breast development, or by 13 with no pubertal development at all, both of which warrant investigation; inability to insert a tampon or have intercourse causing distress; and pain, bleeding, or difficulty during dilation therapy, which should prompt review rather than persistence. These warrant medical assessment, urgently where pain is severe or worsening.